FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

788020005: Antifungal therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3778461019 Antifungal therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3778462014 Antifungal therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antifungal therapeutic role Is a Therapeutic role false Inferred relationship Existential restriction modifier
Antifungal therapeutic role Is a Antiinfective therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release transdermal cream Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely lactic acid 250 milligram/1 gram and salicylic acid 250 milligram/1 gram conventional release cutaneous ointment (clinical drug) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely salicylic acid 110 milligram/1 gram conventional release cutaneous gel (clinical drug) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely selenium sulfide 25 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely salicylic acid 30 milligram/1 milliliter and sulfur 50 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely undecylenic acid 50 milligram/1 milliliter and zinc undecylenate 200 milligram/1 milliliter conventional release cutaneous spray (clinical drug) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely selenium sulfide 25 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely salicylic acid 60 milligram/1 gram conventional release cutaneous gel (clinical drug) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely salicylic acid 50 microgram/1 milligram and zinc oxide 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing boric acid and salicylic acid (medicinal product) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only boric acid and salicylic acid (medicinal product) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing boric acid and salicylic acid in cutaneous dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only boric acid and salicylic acid in cutaneous dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely salicylic acid 170 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing ammonium lactate and salicylic acid in cutaneous dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing salicylic acid and zinc oxide in cutaneous dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing ammonium lactate and salicylic acid (medicinal product) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only salicylic acid and zinc oxide in cutaneous dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only ammonium lactate and salicylic acid (medicinal product) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only ammonium lactate and salicylic acid in cutaneous dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing salicylic acid and sulfur in cutaneous dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely lactic acid (as ammonium lactate) 167 milligram/1 milliliter and salicylic acid 167 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing anthraquinone glycoside and salicylic acid (medicinal product) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only salicylic acid and sulfur in cutaneous dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only anthraquinone glycoside and salicylic acid (medicinal product) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing pentamidine in parenteral dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing pentamidine Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing pentamidine in oral dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Pentamidine Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only pentamidine in oral dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only pentamidine in parenteral dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only pentamidine in pulmonary dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pentamidine isethionate 60 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pentamidine isethionate 300 milligram/1 vial powder for conventional release solution for injection Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing pentamidine in pulmonary dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing nifuratel Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only nifuratel (medicinal product) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely isavuconazole (as isavuconazonium sulfate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing isavuconazonium in parenteral dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only isavuconazonium in parenteral dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clotrimazole 200 milligram/1 each conventional release vaginal pessary (clinical drug) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clotrimazole 500 milligram/1 each conventional release vaginal pessary (clinical drug) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely miconazole 20 milligram/1 gram conventional release oral gel (clinical drug) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely calcium undecylenate 100 milligram/1 gram conventional release cutaneous powder (clinical drug) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Medicinal product containing azole and acting as antifungal agent (product) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Medicinal product containing imidazole and acting as antifungal agent (product) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Medicinal product containing triazole and acting as antifungal agent (product) Plays role False Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amphotericin B liposome 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing clioquinol in otic dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing clioquinol Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only betamethasone and clioquinol in cutaneous dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only clioquinol and flumetasone in otic dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only clioquinol and hydrocortisone in cutaneous dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only clioquinol in cutaneous dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only clioquinol in otic dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only clioquinol (medicinal product) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Flumetasone + Clioquinol Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only clioquinol and fluocinolone (medicinal product) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Hydrocortisone + Clioquinol Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clioquinol 10 milligram/1 milliliter and flumetasone pivalate 200 microgram/1 milliliter conventional release ear drops Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous cream Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing betamethasone and clioquinol Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing clioquinol and hydrocortisone Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing ascorbic acid and clioquinol Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing calamine and clioquinol and zinc oxide Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing clioquinol and fluocinolone Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing clioquinol and flumetasone Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing clioquinol in cutaneous dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing clioquinol and flumetasone in otic dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing clioquinol and hydrocortisone in cutaneous dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only ascorbic acid and clioquinol (medicinal product) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Betamethasone + Clioquinol Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Zinc oxide + Calamine + Clioquinol Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing acetic acid in vaginal dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only acetic acid in vaginal dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing acetic acid and oxyquinoline in vaginal dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only acetic acid and oxyquinoline in vaginal dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely acetic acid 9.2 milligram/1 gram conventional release vaginal gel (clinical drug) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only benzocaine and dequalinium in oromucosal dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing only dequalinium in oromucosal dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Dequalinium Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely benzocaine 10 milligram and dequalinium chloride 250 microgram/1 each conventional release oromucosal lozenge Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dequalinium chloride 250 microgram/1 each conventional release oromucosal lozenge Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing dequalinium Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing benzocaine and dequalinium Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing dequalinium in oromucosal dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing benzocaine and dequalinium in oromucosal dose form (medicinal product form) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Benzocaine + Dequalinium Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Medicinal product containing echinocandin and acting as antifungal agent (product) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Medicinal product containing nitrophenol and acting as antifungal agent (product) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely posaconazole 100 milligram/1 each gastro-resistant oral tablet (clinical drug) Plays role True Antifungal therapeutic role Inferred relationship Existential restriction modifier

Start Previous Page 6 of 11 Next End

This concept is not in any reference sets

Back to Start